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Supplementary Figure 1 MPP8 regulates the type I IFN response.
a Two additional shRNAs against MPP8 (shMPP8_2 and shMPP8_3) were tested for MPP8 depletion 
(left) and ISRE-GFP reporter induction at day 6 compared to the most effective MPP8 shRNA (called 
shMPP8_1 here). N=3 biologically independent samples (right) that were pooled to measure MPP8 
mRNA in technical duplicates (left). Two-tailed unpaired t tests: p=<0.0001 (shMPP8_1), p=0.0428 
(shMPP8_2), and p=0.0407 (shMPP8_3). Control vectors (shEmpty, shControl or shZNF37A) did not 
induce an IFN response. b Extended data from Fig. 1f: MPP8 depletion efficiency in 3 additional cell 
lines. N=3 biologically independent experiments with technical duplicates shown. c Samples from Fig. 
1j were used here to verify that the JAK/STAT inhibitor was able to block expression of endogenous 
ISGs (CXCL10) by qRT-PCR (GAPDH normalized), as well as blocking ISRE-GFP reporter induction. 
N=2 biologically independent samples. d IFN bioassay: supernatants from shRNA-treated 293s were 
added to ISRE-GFP reporter 293 cells and GFP expression measured 24 hours later. N=4 biologically 
independent samples. P=0.0817 (not significant, two-tailed paired t test). e 293 cells containing an 
IFN-beta destabilized GFP reporter used in1 were shRNA-treated and GFP measured 6 days later. N=3 
biologically independent samples. P= 0.0037 (two-tailed paired t test). f 293 cells treated with shRNAs 
in the presence of the JAK/STAT inhibitor Ruxolitinib or DMSO (added from day 1) were harvested for 
qRT-PCR at day 6. N=3 biologically independent samples with technical duplicates shown. Expression 
of CXCL10 was normalized to GAPDH. P=0.0454 (two-tailed paired t test). Data presented in this figure 
show mean values +/- SD, except S1a: left and S1c, which show mean values +/- SEM.
Supplementary Figure 2 MPP8 regulates KZNFs through direct binding.
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Supplementary	Figure	2	MPP8	regulates	KZNFs	through	direct	binding.	
10	out	of	16	KZNFs	that	are	upregulated	in	MPP8-depleted	human	primary	fibroblasts	(HFFs,	see	Fig.	2b)	were	
identified	to	be	bound	by	MORC2	using	publicly	available	ChIP	data	from2	(based	in	the	leukemia	cell	line	K562),	
and	some	examples	are	shown	here.	BigWig	tracks	(see	methods)	are	displayed	from	total	RNA-sequencing	data	
from	this	study	(HFFs,	n=3	biologically	 independent	experiments),	with	normalized	scales	between	shControl	
and	 shMPP8.	Underneath,	HUSH	binding	 profiles	 are	 displayed	using	 public	 ChIP-seq	data	 from	K562	 cells2.	
MORC2	ChIP-seq	peaks	were	called	over	 total	 input	 samples	using	MACS2.	The	MORC2	peaks	were	used	 to	
evaluate	binding	to	KZNF	genes	but	fold	enrichment	over	input	tracks	for	MPP8	and	TASOR	is	also	displayed.		
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Supplementary	Figure	3	Functions	of	genes	directly	and	indirectly	regulated	by	the	HUSH	complex.	
a	 Top:	Venn-Diagram	depicting	 the	number	of	HUSH	complex	binding	peaks	 that	were	uncovered	using	 the	
overlap	 of	 epic2-mapped	 peaks	 for	 MORC2,	 TASOR	 and	 MPP8,	 using	 data	 from2.	 Bottom:	 Venn-Diagram	
annotating	genes	upregulated	in	shMPP8	samples	compared	to	shControls,	using	total	RNA-seq	data	from	HFFs	
(N=6	 biologically	 independent	 experiments)	 and	 including	 HUSH-binding	 data.	 b	 REACTOME	 pathway	
enrichment	analysis	of	upregulated	genes	overlapping	HUSH	peaks	which	are	neither	KZFPs	nor	ISGs	(74),	where	
p-values	are	calculated	based	on	the	hypergeometric	model	and	corrected	for	multiple	testing	with	the	FDR	
method	using	ReactomePA.	c	REACTOME	pathway	enrichment	analysis	of	upregulated	genes	not	overlapped	by	
HUSH	peaks	and	which	are	not	annotated	as	KZFPs	nor	ISGs	(1537),	with	p-adjusted	values	calculated	as	in	b.	d	
HeLa	cells	were	transduced	with	shMPP8	or	shControl	vectors	and	RNA	harvested	3	days	post	shRNAs	for	total	
RNA-sequencing,	confirming	that	genes	involved	in	immunity	are	upregulated	in	an	independent	cell	line.	N=3	
biologically	 independent	experiments.	Upper	plot:	MA	plot	showing	differentially-expressed	genes	 (log2	 fold	
change	>	1	and	a	p-adjusted	value	<0.05).	Example	upregulated	ISGs	are	highlighted	as	well	as	MPP8,	which	is	
downregulated.	Lower	plot:	Gene	set	enrichment	analyses	of	upregulated	genes	in	shMPP8	samples.	e	THP-1	
control	(WT)	or	the	stated	knockout	cell	lines	all	harboring	an	IFIT2-dependent	secreted	Lucia	luciferase	reporter	
were	treated	with	the	stated	agonists	and	luciferase	measurements	scored	24	hours	later.	Background	luciferase	
values	in	non-transfected	controls	were	subtracted	from	all	results.	N=3	biologically	independent	samples.	Data	
are	presented	as	the	mean	+/-	SD.	
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Supplementary Figure 4 MPP8-depletion results in overexpression of LINE-1s and LTRs
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Supplementary	Figure	4	MPP8-depletion	results	in	overexpression	of	LINE-1s	and	LTRs.	
a	Complete	bubble	plot,	part	of	which	was	shown	in	Fig.	4c.	Relative	prevalence	of	all	TE	families	in	the	genome	
by	clade	(purple)	and	relative	abundance	of	overexpressed	TE	families	in	shMPP8	samples	compared	to	controls	
by	 clade	 (blue)	 using	 RNA-seq	 data	 from	 Fig.	 2	 and	 TEtranscripts	 software3.	 N=6	 biologically	 independent	
experiments.	Animal	 images	drawn	by	 lab	members.	b	Upper	 panel:	 TE	 loci	 up	or	 downregulated	 in	MPP8-
depleted	 cells	 (log2	 fold	 change	 >1,	 and	 p	 adjusted	 values	 <0.05	 after	 Benjamini-Hochberg	multiple	 testing	
correction	of	DESeq2-calculated	p-values).	See	datasets	2	and	3	for	exact	p	values.	Results	are	shown	for	loci	
within	the	stated	LTR	families,	which	were	the	most	significantly	affected.	Differential	expression	at	the	family	
level	is	also	displayed	(results	from	using	the	software	TEtranscripts3).	Ns	=	expression	not	significantly	changed.	
Sde	=	significantly	differentially	expressed	(p	adjusted	value	<0.05).	LTR	family	names	with	the	highest	number	
of	upregulated	LTR	loci	are	highlighted	in	blue.	Lower	panel:	Strip	plot	showing	HUSH-bound	(orange)	vs.	not	
known	to	be	bound	(grey)	LTR	loci	with	their	relative	expression	in	shMPP8	samples	compared	to	control.	Boxes	
represent	 1st	 and	 3rd	 quartile,	 where	 the	 central	 line	 corresponds	 to	 the	 median;	 whiskers	 are	 1.5	 of	 the	
interquartile	range.	N=6	biologically	independent	experiments.	c	The	overlap	of	upregulated	TE	loci,	out	of	7432	
total,	and	long	non-coding	RNAs	was	compared	to	1000	randomizations	of	the	same	number	of	random	TEs	or	
of	random	coordinates	with	the	same	size	and	chromosomal	distribution	as	Up-TEs,	where	a	one-sided	p	value	
of		0.000999	was	calculated	as	(1+	no.	of	randomizations	with	a	median	greater	than	the	observed	value)/1,000	
randomizations)	.	LncRNAs	were	taken	from	RNAcentral.	d	The	number	of	RNA-seq	reads	mapping	forward	or	
reverse	strands	of	L1PA2	using	a	HUSH-bound	L1PA2	in	the	human	genome	(chr1:	207733982-207734498,	left)	
or	using	the	L1PA2	consensus	sequence	(right)	were	plotted	for	all	samples.	The	L1PA2	consensus	sequence	was	
stitched	 together	 from	 its	 separated	parts	 available	on	RepBase	 (L1P1_5end+L1P1_orf2+L1PA2_3end).	 Two-
tailed	 unpaired	 t	 test	 values:	 p=0.0007	 (L1PA2	 chr1	 forward)	 and	 p=0.0307	 (L1PA2	 chr1	 reverse),	 p=0.0006	
(L1PA2	 consensus	 forward)	 and	 p=0.0307	 (L1PA2	 consensus	 reverse).	 N=6	 biologically	 independent	
experiments.	 Data	 show	 the	mean	 +/-	 SD.	e	 Coordinates	 of	 bidirectional	 LINE-1s	were	 plotted	 by	 length	 in	
kilobases.	Median:	6.029	Kb	(L1PA1)	and	6.021	Kb	(L1PA2).	
	
Supplementary Figure 5 MPP8 regulates young bidirectional LINE-1s and conserved LINE-1s.
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22 kb
chr1
p36.31 p36.13 p35.3 p34.2 p32.3 p31.3 p31.1 p22.3 p21.3 p13.3 p12 q12 q21.1 q22 q24.1 q25.1 q25.3 q31.2 q32.1 q32.3 q42.11 q42.3 q44
[0 - 7.11]
[0 - 6.90]
[0 - 7.11]
[0 - 6.90]
[0 - 12]
[0 - 10]
[0 - 47]
CR1L
AluSc (ATA)n AluY LTR8B L2a L1PA2 (A)n L1ME4a AluSz6 LTR9B LTR8
20,790 kb 20,800 kb 20,810 kb 20,820 kb
25 kb
chr19
p13.3 p13.2 p13.13 p13.11 p12 p11 q11 q12 q13.11 q13.12 q13.2 q13.31 q13.32 q13.33 q13.41 q13.42 q13.43
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 6.83]
[0 - 5.67]
[0 - 30]
ZNF66 AC010329.1
AluSx4 L1MB2 L1MB2 AluY L1M4b MER5B L1PA3 AluSx AluSp AluSg AluSx1 AluSg4 AluSx
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88,386 kb 88,388 kb 88,390 kb 88,392 kb 88,394 kb 88,396 kb 88,398 kb 88,400 kb 88,402 kb 88,404 kb 88,406 kb 88,408 kb
22 kb
chr12
p13.32 p13.2 p12.3 p12.1 p11.22 p11.1 q12 q13.11 q13.13 q14.1 q14.3 q21.1 q21.2 q21.31 q21.33 q23.1 q23.3 q24.12 q24.22 q24.31 q24.33
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AluSx LOR1-int MIR3 AluY L1PB4 L1PB4 L1PB4 (TGT)n (AT)n MIR L1PA4 MIRb L2b
135,906 kb 135,908 kb 135,910 kb 135,912 kb 135,914 kb 135,916 kb 135,918 kb 135,920 kb 135,922 kb 135,924 kb 135,926 kb
20 kb
chr9
p24.2 p23 p22.2 p21.3 p21.1 p13.2 p11.1 q12 q13 q21.12 q21.2 q21.32 q22.1 q22.32 q31.1 q31.3 q33.1 q33.3 q34.12 q34.3
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 4.46]
[0 - 4.59]
[0 - 19]
CAMSAP1 RP11-432J22.2
(CCG)n L1M4 AluSz L2a AluSx MLT1D MLT1D AluSp AluSc L1MB3 MIRc AluJo AluY AluSq2 MLT1G
Chr 9: 135906675 - 135927549
230,510 kb 230,520 kb 230,530 kb 230,540 kb
25 kb
chr2
p25.2 p24.3 p23.3 p22.3 p21 p16.2 p15 p13.3 p12 p11.2 q11.2 q12.3 q14.2 q21.1 q22.1 q23.1 q24.1 q24.3 q31.2 q32.2 q33.1 q34 q35 q36.2 q37.2
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 6.45]
[0 - 3.92]
[0 - 20]
SP100 AC010149.4 SP100
GA-rich AluSx LTR49-int LOR1-int AluJb L1PA6 LOR1-int AluY AluSz AluJb ERVL-B4-int
110,890 kb 110,900 kb 110,910 kb 110,920 kb
25 kb
chr6
p25.1 p24.1 p22.3 p22.2 p21.32 p21.1 p12.3 p12.1 q11.1 q13 q14.1 q14.3 q16.1 q16.3 q21 q22.1 q22.32 q23.2 q24.1 q24.3 q25.2 q26 q27
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 4.18]
[0 - 3.92]
[0 - 8.69]
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(AATA)n AluSz (TA)n AluSq2 MIR FLAM_C L1PA5 AluY MIRb L1MB8 L1MD2 L1MA10 HERVK9-int
Chr 6: 116727847 - 116748084
Chr 1
Chr 16: 72617274 - 72643298
67,070 kb 67,080 kb 67,090 kb
25 kb
chr1
p36.23 p36.12 p35.1 p34.1 p32.2 p31.2 p22.3 p21.3 p13.3 p12 q12 q21.1 q22 q24.1 q25.2 q31.1 q32.1 q32.3 q42.11 q42.3 q44
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 50]
[0 - 3.42]
[0 - 3.31]
[0 - 3.10]
C1orf141
AluY L1MB1 L1MB1 L1MD3 L2a AluJb L1HS AluJr L3 AluSz L1MEj L2a
66,270 kb 66,280 kb 66,290 kb 66,300 kb
25 kb
chr7
p22.1 p21.2 p15.3 p14.3 p14.1 p12.3 p11.2 q11.21 q11.23 q21.12 q21.3 q22.2 q31.1 q31.31 q32.1 q33 q34 q36.1 q36.3
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[0 - 50]
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[0 - 3.04]
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HAL1M8 L1PREC2 MIRb AluSz (TTTTA)n L1HS AluY L1ME4a L2c AluY AluSx L1MEf
Chr 1: 67070000 - 67090500
Chr 7: 66276854 - 66302884
Chr 1: 207723357 - 207745584
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* Note that upregulation of bidirectional L1HS/L1PA2 in the shMPP8 is mainly only detectable
  when mapping reads to the L1HS/L1PA2 consensus while the above screenshots show 
  evidence for bidirectional expression of loci ( in all samples) using only uniquely-mapping reads.
Supplementary	Figure	5	MPP8	regulates	young	bidirectional	LINE-1s	and	conserved	LINE-1s.	
BigWig	tracks	of	stranded	RNA-seq	data	(HFFs)	mapped	to	the	genome	(hg38)	are	shown	for	example	loci	(scales	
are	normalized	between	shControl	and	shMPP8	for	the	same	strand).	Additionally,	ChIP-seq	tracks	are	shown	
using	publicly-available	ChIP-seq	data	 (for	MPP8,	 TASOR	and	MORC2)	 from	K562	 cells2:	MORC2	peaks	were	
called	over	total	input	samples	using	MACS2.	On	the	left	are	examples	of	LINE-1	elements	that	were	scored	as	
bidirectionally	 expressed	 (mainly	 L1PA1	 and	 L1PA2).	 Note	 that	 these	 young	 LINE-1	 elements	 are	 already	
expressed	in	control	cells.	Since	we	are	mapping	unique	reads	only	to	avoid	false	positives,	it	is	difficult	to	map	
a	potential	increase	in	L1PA1	expression	at	the	loci	level	due	to	mappability	issues	of	young	LINE-1s	but	an	overall	
increase	in	L1PA1	expression	can	be	mapped	by	mapping	reads	to	the	L1PA1	consensus	sequence	(see	Fig.	4g).	
On	the	right	are	examples	of	LINE-1	loci	scored	as	upregulated	in	MPP8-depleted	cells	(mainly	LINE-1s	conserved	
in	primates).	N=6	biologically	independent	experiments.	
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Supplementary Figure 6 LINE-1s drive IFN and MPP8-depletion induces DNA damage.
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Supplementary	Figure	6	LINE-1s	drive	IFN	and	MPP8-depletion	induces	DNA	damage.	
a	While	there	may	be	multiple	mechanisms	contributing	to	the	ISG	response	in	HUSH-depleted	cells,	we	opted	
to	focus	on	the	possible	role	of	LINE-1	elements	and	related	Alu	and	SVA	elements.	b	Left:	293	reporter	cells	
were	treated	with	shRNAs	 in	the	presence	of	the	stated	reverse	transcriptase	 inhibitors	(RTis)	or	DMSO	as	a	
control	(added	from	day	1)	for	the	duration	of	the	experiment.	GFP	was	measured	by	FACS	on	day	6	and	the	
mean	fluorescent	intensity	(MFI)	was	set	at	100%	of	the	DMSO	control	and	the	other	samples	normalized	to	
this.	N=4	biologically	 independent	experiments.	Right:	 In	parallel,	 the	same	doses	of	 inhibitors	were	used	to	
block	transduction	of	a	PGK-GFP	lentivector	in	293T	cells.	N=3	biologically	independent	experiments.	c	Left:	293	
reporter	cells	were	treated	with	shRNAs	and	transfected	the	next	day	with	cognate	KZNFs/KAP1	or	ZFP819	as	a	
control.	 GFP	 MFI	 in	 control	 samples	 (transfection	 reagent	 control)	 were	 set	 at	 100%	 and	 other	 samples	
normalized	to	this.	N=5	biologically	independent	experiments	with	all	treatments	each	performed	in	at	least	3	
experiments.	Two-tailed	unpaired	t	test	values:	p=<0.0001	(ZNF91)	and	p=0.0070	(ZNF93).	Right:	In	parallel,	the	
stated	KZNFs	were	tested	functionally	by	co-transfecting	them	with	luciferase	reporter	plasmids	containing	their	
binding	sites	and	a	renilla	control	plasmid	as	used	before4.	N=3	biologically	independent	samples.	d	293	reporter	
cells	were	co-transduced	with	the	indicated	vectors	and	endogenous	expression	of	LINE-1s	was	measured	using	
L1PA2-3	 primers	 (see	 Supplementary	 Table	 2).	 N=2	 biologically	 independent	 experiments	 with	 technical	
triplicates	shown.	e	Using	The	Cancer	Genome	Atlas	 (TCGA)	data,	we	selected	cancers	 for	which	there	were	
matched	control	samples	as	well	as	GTEx	expression	data	from	the	same	tissue.	PPHLN1	and	TASOR	expression	
levels	are	scored	here	and	are	not	significantly	changed	in	expression	in	cancers.	See	Fig.	6a	for	MPP8.	f	HeLa	
cells	were	 treated	with	shRNAs	before	yH2AX	staining.	N=2	biologically	 independent	 samples.	 Left:	Example	
yH2AX	staining	images.	Right:	summary	data	of	yH2AX	foci	/	nucleus.	All	data	show	the	mean	+/-	SD,	except	for	
S6f,	where	the	mean	+/-	SEM	is	shown.	
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Supplementary Figure 7  Gating strategy used for flow cytometry analyses. 
Cells were selected (side scatter (SSC) vs. forward scatter (FSC) ) and the level of GFP expression 
analysed within that population. Non-transduced cells were used as negative controls to define the 
gate of GFP-positive cells (GFP+) in test samples. When histograms were overlayed from different
samples, they were normalized to mode (using Flowjo software) as stated on the y axis.
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Supplementary	Table	1:	shRNA	and	sgRNA	sequences	
	
	
	
	
shRNA	sequences
Hairpin	name Hairpin	target Designed	on No.	of	matches %	L1	matches L1	subfamily	with	most	hits
shControl GTTATAGGCTCGCAAAAGG non-targeting	shRNA 0 0 NA
shTASOR GAGGAAGCTTGAGGATCTA TASOR	CDS	(exon	14)	 1 0 NA
shPPHLN1 AGCTAACCACTCGCTCTAA PERIPHILIN	CDS	(exon	9) 1 0 NA
shMPP8 ACCAGAGACGAAACGGATA MPP8	CDS	(exon	9) 1 0 NA
shMPP8_2 CCGGCAAGCTGTAGTTCTGAATGAT MPP8	CDS	(exon	12),	shRNA	TRCN0000117925 1 0 NA
shMPP8_3 CCGGGCTAGAGAACAAGAACGCTTT MPP8	CDS	(exon	3),	shRNA	TRCN0000117926 1 0 NA
shL1PA1_5'UTR CACCGAAAACCCATCTGTA L1HS	5'UTR	(RepBase) 584 100L1PA1	(288	copies)	and	L1PA2	(271	copies)
shL1PA4_ORF2 TGGGCAAGGACTTCATATC L1PA4	ORF2	on	chr11,	MPP8-bound	using	ChIP	from:	Liu	et	al.,	Nature	201836 100 L1PA4	(47	copies)*
shL1_c ACCCGAATACTGCGCTTTT L1PA2	5'UTR	on	chr1,	MPP8-bound	using	ChIP	from:	Liu	et	al.,	Nature	2018678 100 L1PA3	(370	copies)
shL1_d AGCAAATGCTGAGGGAATT L1PA10	ORF1	on	chr2,	MPP8-bound	using	ChIP	from:	Liu	et	al.,	Nature	2018408 100 L1PA10	(135	copies)
shL1_e GCATAACTGGCTAGCCATA L1PA15	ORF2	on	chr19,	MPP8-bound	using	ChIP	from:	Liu	et	al.,	Nature	201831 100 L1PA13	(10	copies)
shL1_f GCAACATAGATGGAGCTGA L1PA15	ORF2	on	chr19,	MPP8-bound	using	ChIP	from:	Liu	et	al.,	Nature	2018 100 L1PA15	(3	copies)
shAlu CCTGTAATCCCAGCACTTT Alu	(RepBase) 9600 100%	Alu NA
shMOV10 GGGTCAGATATCAGCAAAC MOV10	CDS	(exon	2) 1 0 NA
NA	=	not	applicable
CDS	=	coding	sequence
*	this	hairpin	recognizes	136	LINE-1	loci	in	total	from	subfamilies	L1PA1	to	L1PA5.
sgRNA	sequences
Human	RIG-I
G1 score	82 negative	strand target	seq TTGCAGGCTGCGTCGCTGCT
target	seq	with	GGTGCAGGCTGCGTCGCTGCT
Fwd	primer CACCGTGCAGGCTGCGTCGCTGCT
Rvs	primer AAACAGCAGCGACGCAGCCTGCAC
G2 score	89 positive	strand target	seq GGATTATATCCGGAAGACCC
target	seq	with	G
Fwd	primer CACCGGATTATATCCGGAAGACCC
Rvs	primer AAACGGGTCTTCCGGATATAATCC
Human	MDA5
G3 score	92 negative	strand target	seq ATAGCGGAAATTCTCGTCTG
target	seq	with	GGTAGCGGAAATTCTCGTCTG
Fwd	primer CACCGTAGCGGAAATTCTCGTCTG
Rvs	primer AAACCAGACGAGAATTTCCGCTAC
G4 score	93 positive	strand target	seq TGGTTGGACTCGGGAATTCG
target	seq	with	GGGGTTGGACTCGGGAATTCG
Fwd	primer CACCGGGTTGGACTCGGGAATTCG
Rvs	primer AAACCGAATTCCCGAGTCCAACCC
Clones	made	from	sgRNAs	in	bold	are	shown	in	Figure	3
Supplementary	Table	2:	Primers	
	
qRT-PCR		
	
Primer	name	
	
Forward	
	
Reverse	
MPHOSPH8	
(MPP8)	
TGCCTGTATCTGCCCAAAC	 CCTTGTCAGAATCATGCCTTTTC	
PPHLN1	
(Periphilin)	
GGTTCCAGTGTCAGTAGCAG	 TCATTCTGCCGTTTGTAGGAG	
FAM208A	
(TASOR)	
TGAAGACATTGCAGGTTTCATTC	 CATCCAGGCTATCAACACCAG	
B2M	 TGCTCGCGCTACTCTCTCTTT	 TCTGCTGGATGACGTGAGTAAAC	
GAPDH	 GGGAAACTGTGGCGTGAT	 GGAGGAGTGGGTGTCGCTGTT	
IFIT1	 CCTGAAAGGCCAGAATGAGG	 TCCACCTTGTCCAGGTAAGT	
IFIT2	 ACTATGCCTGGGTCTACTATCA	 TCAAGCTCTGGACTCTCAATTC	
CCL5	 CCCAGCAGTCGTCTTTGTCA	 TCCCGAACCCATTTCTTCTCT	
CXCL10	 GTGGCATTCAAGGAGTACCTC	 GCCTTCGATTCTGGATTCAGA	
MXA	 ATCCTGGGATTTTGGGGCTT	 CCGCTTGTCGCTGGTGTCG	
	
	
qRT-PCR	primers	against	human	LINE-1s	
	
Name	 Forward	 Reverse	
No.	of	constrained	
exact	hits*	
%	hits	to	LINE-
1s	
L1PA2-3	
GGAAATCATCATTCTCAGTAAAC	 CACAGTCCCCAGAGTGTGATAT	 1373	
	
100	
L1PA4	
TCACCAATATCCGCTGTTCTG	 GTCTGTTGGAGTTTACTGGAGG	 52	
	
100	
	
*	Blast	hits	with	100%	identity	and	full	coverage,	where	the	forward	and	reverse	primer	hits	are	located	within	
200	bps	of	each	other	on	opposite	strands	
	
Breakdown	of	repeat	primer	hits	to	repeat	subfamilies	
	
L1PA2-3	primers	
No.	of	hits	 Repeat	
1219	 	 L1PA2	
145	 L1PA3	
9	 L1PA1	
1	 L1P1	
	
	
L1PA4	primers	
No.	of	hits	 Repeat	
43	 L1PA4	
5	 L1P1	
2	 L1PA5	
1	 L1PA6	
1	 L1PA3	
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